Clinical Kidney Journal

Papers
(The H4-Index of Clinical Kidney Journal is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Prolonged normothermic perfusion: a promising approach to kidney transplantation217
A puzzling renal Fanconi syndrome108
Donor-derived membranous nephropathy93
Toward acid- and heparin-free dialysis: the regional anticoagulation approach69
Circulating miR-129-3p in combination with clinical factors predicts vascular calcification in hemodialysis patients68
Correction to: Recognition of intraglomerular histological features with deep learning in protocol transplant biopsies and their association with kidney function and prognosis68
Can exercise improve outcomes for frail haemodialysis patients?62
Complement activation in anti-glomerular basement membrane disease before and after treatment with imlifidase60
The “Leicester, Leicestershire, and RUtland Chronic Kidney Disease Integrated Care Delivery Project” (LUCID) programme update: the impact on novel kidney therapies60
Bilateral nephrectomy in autosomal dominant polycystic kidney disease patients before or after renal transplantation: data from a retrospective cohort study59
Standardization of serum creatinine is essential for accurate use of unbiased estimated GFR equations: evidence from three cohorts matched on renal function57
Cerebral blood flow following successful living kidney transplantation: the VINTAGE study56
Obinutuzumab treatment for membranous nephropathy: effectiveness and safety concerns during the COVID-19 pandemic55
Non-invasive assessment of IgA nephropathy severity with [18F]AlF-NOTA-FAPI-04 PET/CT imaging51
The use of SGLT2 inhibitors and GLP-1 receptor agonists in older patients: a debate on approaches in CKD and non-CKD populations51
Making use of avacopan in clinical practice50
Ten tips on how to manage kidney health in migrants and refugees48
Ten tips on management of BK nephropathy in kidney transplant patients47
Performance of the race-free CKD-EPI creatinine-based eGFR equation in a Danish cohort with measured GFR46
The spectrum of diseases, genetic landscape and new mutation sites of hereditary cystic kidney disease45
Differentiating primary and secondary FSGS using non-invasive urine biomarkers43
Meet and greet but avoid the heat: a reflection on the carbon footprint of congresses prompted by ERA202343
Causal relationships between immune cell phenotypes and primary glomerular diseases: genetic evidence from bidirectional Mendelian randomization study42
ECOSBot: a multicenter validation pilot study of a generative AI tool for OSCE-based nephrology training42
Association between frailty and bone health in early-stage chronic kidney disease: a study from the population-based CARTaGENE cohort41
Plant-based diets for CKD patients: fascinating, trendy, but feasible? A green nephrology perspective41
10 tips on performing economic evaluation in kidney disease41
Microvascular perfusion, perfused boundary region and glycocalyx shedding in patients with autosomal dominant polycystic kidney disease: results from the GlycoScore III study41
Interaction of general obesity and abdominal obesity with frailty in patients with chronic kidney disease: a nationally representative analysis41
Alleviating symptoms in patients undergoing long-term hemodialysis: a focus on chronic kidney disease-associated pruritus39
Novel eGFR equations and cardiovascular outcomes in a multiethnic Asian cohort39
But how green is it actually? Calculating the environmental footprint of kidney care environmental optimizations within haemodialysis37
Recent advances in pathogenetic concepts and disease modeling of IgA nephropathy37
Efficacy and safety of telitacicept, a BLyS/APRIL dual inhibitor, in the treatment of IgA nephropathy: a retrospective case–control study37
Use of eHealth and remote patient monitoring: a tool to support home dialysis patients, with an emphasis on peritoneal dialysis36
Safety and efficacy of glucagon-like peptide-1 receptor agonists among kidney transplant recipients: a systematic review and meta-analysis36
Erythroferrone is associated with the hepcidin-to-ferritin ratio and cardiovascular mortality in chronic kidney disease36
0.13403105735779